Elite Pharmaceuticals, Inc. Appoints Dr. Jason M. LePree as Vice President of Scientific Affairs
NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical...
Month: January 2021
Jason Nemes Increases Quality of Life by Changing Perspectives
AUSTIN, TX / ACCESSWIRE / January 5, 2021 / While it is an issue everyone is familiar with, talking about...
AsclepiX Therapeutics, Inc. Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for Diabetic Macular Edema (DME)
BALTIMORE, MD / ACCESSWIRE / January 5, 2021 / AsclepiX Therapeutics, Inc., a biopharmaceutical company using computational biology to identify potent peptide...
Hepion Pharmaceuticals to Participate in Upcoming January Virtual Investor Conferences
EDISON, NJ / ACCESSWIRE / January 5, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a clinical stage biopharmaceutical company focused on...
Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics
HACKENSACK, NJ / ACCESSWIRE / January 5, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that...
Capsule and Retia Medical Collaborate on Argos Cardiac Monitor to Streamline Device Interoperability, Protect Patient Safety
ANDOVER, Mass. and VALHALLA, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Retia Medical is the first company to utilize Capsule...
Progyny, Inc. to Present at the 39th Annual JP Morgan Healthcare Conference
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility...
Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered
DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of effective and environmentally...
Revel + NovuHealth Become Icario
Nation's leading health action company reveals new brand reflecting the company’s mission to connect people to healthMINNEAPOLIS, Jan. 05, 2021...
Exergen Provides Critical Protective Equipment to School of Nursing Students
Protecting Those Who Protect UsWATERTOWN, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Northeastern University’s School of Nursing, part of the...
Cannabinoid Non-Profit ECHO Connection Appoints Brian Higuera as New Company President and Chairman of the Board of Directors
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ECHO Connection (the “Company”), a non-profit charitable organization dedicated to...
Adverum Biotechnologies to Present at 39th Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting...
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
FLORHAM PARK, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Genenta to Take Part in Gene Therapy Panel and Two Virtual Investor Events in January 2021
MILAN, Italy and NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development...
CV Sciences, Inc. Announces Launch of ProCBD™ Product Line
Clinical Strength ProCBD™ is Supported by Clinical Research and Available Exclusively Through Health Practitioners CV Sciences, Inc. Announces Launch of...
Ultragenyx to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference
NOVATO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
Medigene to Take Part in Cell Therapy Panel at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
MARTINSRIED, Germany and MUNICH, Germany, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Medigene AG (FSE: MDG1, Prime Standard), a clinical stage...
Nxt-ID, Inc. Regains Compliance With Nasdaq Minimum Bid Price Requirement
Bid Price of Listed Securities Exceeds $1 at Closing for Eleven Consecutive Trading Days Oxford, Connecticut, Jan. 05, 2021 (GLOBE...
Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences
BOSTON, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel...
Allogene Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...